Investor directoryDroia Ventures
Droia Ventures is dedicated to making an impact in life sciences by investing exclusively in therapeutics that address significant unmet medical needs.
The facts
- Typical cheque
- €1M – €30M
- Headquarters
- Zaventem, Belgium
- Founded
- 2011
Portfolio companies
More portfolio companies
Vico TherapeuticsArcus Biosciences (NYS: RCUS)Frontier MedicinesPACT PharmaAura Biosciences (NAS: AURA)Hummingbird BioscienceProtego BiopharmaQurAlisUnnatural ProductsVolastraVaderis TherapeuticsJudo BioHillstar BioMuna TherapeuticsOctimet OncologyVicinitas TherapeuticsHyku BiosciencesMahzi TherapeuticsSummation BioAnanke TherapeuticsMontis BiosciencesConvert PharmaceuticalsAccent TherapeuticsActio Biosciences
and 5 more
Recent rounds
Vaderis Therapeutics
USD 152 millionSeries BBiotech & PharmaTCGXleadLife SciencesleadGoldman SachsleadDroia VenturesOmega FundsPerceptive Advisors · +4 more in the source
Switzerlandprnewswire.com
Rounds Droia Ventures took part in, as reported by the linked articles. See who else is investing right now.
Questions founders ask
- How much does Droia Ventures typically invest?
- Droia Ventures states a typical cheque of €1M – €30M.
- Which stages does Droia Ventures invest in?
- Droia Ventures invests at Seed, Series A, Pre-Seed and Series B.
- Where is Droia Ventures based?
- Droia Ventures is headquartered in Zaventem, Belgium.
Does Droia Ventures fit your round?
In 30 minutes you'll know which funds matter for your round.
Get a demoSearch investors like this in Claude — no account, no sign-in. Open in Claude
Are you Droia Ventures? Tell us what to correct and we will update it — or ask us to remove the entry.